https://www.thehindu.com/sci-tech/health/why-india-rejected-a-patent-application-for-shorter-drug-resistant-tb-treatment-explained/article71639506.ece
The decision could open the door to greater generic competition, but its impact on treatment costs will depend on drug availability, pricing, and access to care
Image:
The decision could open the door to greater generic competition, but its impact on treatment costs will depend on drug availability, pricing, and access to care
Image:
Views: 4
Categories: General [c1]